MR-visible coatings for endovascular device visualization.
OBJECTIVE
To investigate the potential utility of magnetic resonance (MR)-visible coatings for passive visualization of therapeutic endovascular devices such as catheters and guidewires.


METHODS
Using a multistep coating process, gadolinium-based coatings were applied to commercially available off-the-shelf catheters and guidewires. These coated devices were imaged in phantoms made of fat-free yogurt, saline, and whole blood and also in live canine aorta on a 1.5-T cardiovascular MR scanner using T1-weighted two-dimensional radiofrequency (RF)-spoiled gradient-recalled echo, two-dimensional spin echo, and three-dimensional RF-spoiled gradient-recalled echo techniques.


RESULTS
Commercially available off-the shelf catheters (4, 5, and 6 French) and guidewires (0.038 inch) were clearly visualized in all phantoms and canine aorta and the coatings proved to be durable and imageable without degradation in signal intensity up to 24 hours. MR-visible coatings address some of the shortcomings that have previously limited the role of MR as a guidance tool.


CONCLUSIONS
Both in vitro and in vivo visualization of therapeutic endovascular devices coated with MR-visible coatings are found to be clinically viable.
Unal
Orhan
O
Department of Medical Physics, University of Wisconsin, Madison, WI 53792-1590, USA. unal@wisc.edu
Li
Junwei
J
Cheng
Weiguo
W
Yu
Hyuk
H
Strother
Charles M
CM
D015761:4-Aminopyridine / Q000031:analogs & derivatives; D000818:Animals; D001011:Aorta / Q000033:anatomy & histology; D002404:Catheterization / Q000295:instrumentation*; D002614:Chelating Agents; D020099:Coated Materials, Biocompatible; D004024:Dicyclohexylcarbodiimide; D004121:Dimethyl Sulfoxide; D004285:Dogs; D004867:Equipment Design; D005240:Feasibility Studies; D019786:Gadolinium DTPA / Q000737:chemistry*; D020136:Hydrogel, Polyethylene Glycol Dimethacrylate; D021621:Imaging, Three-Dimensional / Q000379:methods; D066298:In Vitro Techniques; D008279:Magnetic Resonance Imaging; D019047:Phantoms, Imaging; D011725:Pyridines; D015641:Radiography, Interventional / Q000379:methods; D012997:Solvents; D013997:Time Factors
D002614:Chelating Agents; D020099:Coated Materials, Biocompatible; D011725:Pyridines; D012997:Solvents; D020136:Hydrogel, Polyethylene Glycol Dimethacrylate; D004024:Dicyclohexylcarbodiimide; D015761:4-Aminopyridine; D019786:Gadolinium DTPA; C023666:pyridine; C003885:4-dimethylaminopyridine; D004121:Dimethyl Sulfoxide